Literature DB >> 11157432

Cerebral white matter lesions in bipolar affective disorder: relationship to outcome.

P B Moore1, D J Shepherd, D Eccleston, I C Macmillan, U Goswami, V L McAllister, I N Ferrier.   

Abstract

BACKGROUND: Twenty per cent of patients with bipolar affective disorder suffer an illness that responds inadequately to treatment and has a poor outcome. Many patients, but not all, with bipolar disorder show white matter abnormalities on T(2)-weighted magnetic resonance imaging (MRI). AIMS: To explore the hypothesis that white matter abnormalities on MRI are seen more frequently in subjects whose illness has a poor outcome compared with those with a good outcome or controls.
METHOD: Two groups of age- and gender-matched patients with bipolar disorder (14 with a good outcome and 15 with a poor outcome) and 15 controls, aged 20-65 years, were studied. Axial T(2)-weighted MRI scans were examined for the presence and severity of white matter abnormalities.
RESULTS: Significantly more poor outcome group members had deep subcortical punctate, but not periventricular, white matter hyperintensities than the good outcome group (P:=0.035) or controls (P:=0.003) and these abnormalities were of greater severity (P:=0.030 and P:<0.014, respectively).
CONCLUSIONS: Subcortical white matter lesions are associated with poor outcome bipolar disorder.

Entities:  

Mesh:

Year:  2001        PMID: 11157432     DOI: 10.1192/bjp.178.2.172

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  26 in total

Review 1.  Diffusion tensor imaging and its application to neuropsychiatric disorders.

Authors:  Marek Kubicki; Carl-Fredrik Westin; Stephan E Maier; Hatsuho Mamata; Melissa Frumin; Hal Ersner-Hershfield; Ron Kikinis; Ferenc A Jolesz; Robert McCarley; Martha E Shenton
Journal:  Harv Rev Psychiatry       Date:  2002 Nov-Dec       Impact factor: 3.732

Review 2.  Staging bipolar disorder.

Authors:  Eduard Vieta; M Reinares; A R Rosa
Journal:  Neurotox Res       Date:  2010-05-12       Impact factor: 3.911

Review 3.  Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review.

Authors:  John L Beyer; Robert Young; Maragatha Kuchibhatla; K Ranga R Krishnan
Journal:  Int Rev Psychiatry       Date:  2009

Review 4.  White matter hyperintensities: from medical comorbidities to bipolar disorders and back.

Authors:  Eva Gunde; Ryan Blagdon; Tomas Hajek
Journal:  Ann Med       Date:  2011-07-13       Impact factor: 4.709

5.  Total white matter hyperintensity volume in bipolar disorder patients and their healthy relatives.

Authors:  Sarah K Tighe; Sarah A Reading; Paul Rivkin; Brian Caffo; Barbara Schweizer; Godfrey Pearlson; James B Potash; J Raymond Depaulo; Susan S Bassett
Journal:  Bipolar Disord       Date:  2012-12       Impact factor: 6.744

6.  The effects of type 1 diabetes on cerebral white matter.

Authors:  K Weinger; A M Jacobson; G Musen; I K Lyoo; C M Ryan; D C Jimerson; P F Renshaw
Journal:  Diabetologia       Date:  2007-12-18       Impact factor: 10.122

Review 7.  Neurocognitive and neuroimaging predictors of clinical outcome in bipolar disorder.

Authors:  Carrie E Bearden; Michelle Woogen; David C Glahn
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

8.  Enlargement of the Third Ventricle in affective disorders.

Authors:  Rano Bhadoria; David Watson; Paul Danson; Ian Nicol Ferrier; Victor I McAllister; Peter Brian Moore
Journal:  Indian J Psychiatry       Date:  2003-07       Impact factor: 1.759

9.  Memantine in the management of a clinically challenging case of bipolar disorder.

Authors:  Vivek Agarwal; Adarsh Tripathi
Journal:  Indian J Psychiatry       Date:  2009-04       Impact factor: 1.759

10.  A voxel-based diffusion tensor imaging study of white matter in bipolar disorder.

Authors:  Katie Mahon; Jinghui Wu; Anil K Malhotra; Katherine E Burdick; Pamela DeRosse; Babak A Ardekani; Philip R Szeszko
Journal:  Neuropsychopharmacology       Date:  2009-01-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.